跳至主要内容
临床试验/CTRI/2019/03/018332
CTRI/2019/03/018332尚未招募4 期

Optimal dose of prophylactic intravenous infusions of norepinephrine for prevention of hypotension post spinal anaesthesia in elective Caesarean section

Dr LH Hiranandani Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All ASA2 parturients with singleton full term pregnancy for elective LSCS.
  • Patients giving valid consent
  • Gestational age 37 to 40 weeks

排除标准

  • Patient refusal
  • Patient on any medication that influences the cardiovascular system
  • Patients with PIH/eclampsia
  • Maternal heart disease or coagulopathies
  • Placenta previa, uterine myomas
  • Patients with contraindication to regional anaesthesia
  • Inadequate action of spinal anaesthesia and conversion to general anaesthesia
  • History of seizures or progressive neurologic disease

研究者

发起方
Dr LH Hiranandani Hospital

相似试验